Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis

Authors :: Claudius Speer
Maximilian Töllner
Louise Benning
Katrin Klein
Marie Bartenschlager
Christian Nusshag
Florian Kälble
Paula Reichel
Paul Schnitzler
Martin Zeier
Christian Morath
Wilhelm H Schmitt
Raoul Bergner
Ralf Bartenschlager
Matthias Schaier
Source :: Annals of the Rheumatic Diseases. 81:593-595
Publication Year :: 2022
Publisher :: BMJ, 2022.

Subjects :: Adult
Immunosuppression Therapy
Male
SARS-CoV-2
Immunology
COVID-19
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Middle Aged
General Biochemistry, Genetics and Molecular Biology
Immunity, Humoral
Immunogenicity, Vaccine
Rheumatology
Humans
Immunology and Allergy
Female
Prospective Studies
BNT162 Vaccine

Full Text Access

Tools